Support our work
Decorative header background

Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson’s disease

Research group Verhaagen
Publication year 2017
Published in The Journal of neuroscience : the official journal of the Society for Neuroscience
Authors J.A. Korecka, E. Moloney, R. Eggers, B. Hobo, S Scheffer, N Ras-Verloop, R Jeroen Pasterkamp, D.F. Swaab, A. Smit, Ronald E van Kesteren, K. Bossers, J. Verhaagen

Repulsive guidance molecule member a (RGMa) is a membrane-associated or released guidance molecule that is involved in axon guidance, cell patterning and cell survival. In our previous work we showed that RGMa is significantly upregulated in the substantia nigra of patients with Parkinson’s disease. Here we demonstrate the expression of RGMa in midbrain human dopaminergic neurons. To investigate whether RGMa might model aspects of the neuropathology of Parkinson’s disease in mouse, we targeted RGMa to adult midbrain dopaminergic neurons using adeno-associated viral vectors. Overexpression of RGMa resulted in a progressive movement disorder, including motor coordination and imbalance, which is typical for a loss of dopamine (DA) release in the striatum. In line with this, RGMa induced selective degeneration of dopaminergic neurons in the SN and affected the integrity of the nigrostriatal system. The degeneration of dopaminergic neurons was accompanied by a strong microglia and astrocyte activation. The behavioral, molecular and anatomical changes induced by RGMa in mice are remarkably similar to the clinical and neuropathological hallmarks of Parkinson’s disease. Our data indicate that dysregulation of a repulsive axon guidance cue (RGMa) plays an important role in the pathology of Parkinson’s disease and antibody-mediated functional interference with RGMa may be a disease modifying treatment option.SIGNIFICANCE STATEMENTParkinson’s disease (PD) is a neurodegenerative disease characterized by severe motor dysfunction due to progressive degeneration of mesencephalic dopaminergic (DA) neurons in the substantia nigra (SN). To date there is no regenerative treatment available. We previously showed that repulsive guidance molecule member a (RGMa) is upregulated in the SN of PD patients. AAV-mediated targeting of RGMa to mouse DA neurons showed that overexpression of this repulsive axon guidance and cell patterning cue models the behavioral and neuropathological characteristics of PD in a remarkable way. These findings have implications for therapy development as interfering with the function of this specific axon guidance cue may be beneficial to the survival of DA neurons.

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.

Support our work